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Summary
Natural killer (NK) cells recognize the absence of self
MHC class I as a way to discriminate normal cells
from cells in distress. In humans, this ‘‘missing self’’
recognition is ensured by inhibitory receptors such
as KIR, which dampen NK cell activation upon interac-
tion with their MHC class I ligands. We show here that
NK cells lacking inhibitory KIR for self MHC class I mol-
ecules are present in human peripheral blood. These
cells harbor a mature NK cell phenotype but are hypo-
responsive to various stimuli, including MHC class
I-deficient target cells. This response is in contrast to
NK cells that express a single inhibitory KIR specific
for self MHC class I, which are functionally competent
when exposed to the same stimuli. These results show
the involvement of KIR-MHC class I interactions in the
*Correspondence: ugolini@ciml.univ-mrs.fr (S.U.); vivier@ciml.
univ-mrs.fr (E.V.)calibration of NK cell effector capacities, suggesting
its role in the subsequent ‘‘missing self’’ recognition.
Introduction
Major histocompatibility complex (MHC) class I mole-
cules are critical elements of the vertebrate adaptive im-
mune response, via their function as antigen-presenting
molecules to T cells. MHC class I molecules are also rec-
ognized by several inhibitory receptors expressed on
innate effectors, in particular NK cells (Hoglund et al.,
1997; Parham, 2005; Raulet et al., 2001; Yokoyama and
Plougastel, 2003). NK cells are large granular lympho-
cytes that are involved in innate immunity against vi-
ruses, bacteria, parasites, and other triggers of pathol-
ogy, such as malignant transformation, all of which
cause stress in affected cells (Moretta et al., 2002; Mor-
etta and Moretta, 2004). NK cell responses are mediated
by two major effector functions: direct cytolysis of target
cells and production of chemokines and cytokines.
Through the latter (e.g., interferon-g [IFN-g]), NK cells
participate to the shaping of the adaptative T cell re-
sponse (Martin-Fontecha et al., 2004). NK cell activity is
governed by the dynamic balance between signals that
either cooperate with or antagonize each other (Long,
1999; Vivier et al., 2004). The combinatorial engagement
of activating and inhibitory cell-surface receptors deter-
mines whether NK cells will or will not kill target cells and/
or produce cytokines during their effector phase of acti-
vation (Vivier et al., 2004).
NK cells express inhibitory receptors for MHC class I
molecules, i.e., receptors for MHC class I molecules
that are able to dampen NK cell effector function upon
ligation. These inhibitory receptors include KIR (killer
cell Ig-like receptors) in humans, Ly49 in the mouse,
and CD94/NKG2A heterodimers in both species (Par-
ham, 2005; Raulet et al., 2001). KIR and Ly49 loci are
extremely polymorphic, both in terms of gene numbers
and alleles present (Parham, 2005; Trowsdale, 2001).
The variegated expression of these genes adds to the
complexity of NK cell MHC class I recognition (Parham,
2005; Raulet et al., 2001). In humans, KIR can harbor two
(KIR2D) or three (KIR3D) extracellular C2-type Ig-like do-
mains. KIR recognize groups of HLA class I molecules
that are determined by the amino acids belonging to
the C-terminal portion of the MHC class I a1 helix (Boy-
ington and Sun, 2002). In particular, the recognition of
inhibitory KIR2D depends to a large extent on the nature
of the MHC class I amino acid present at position 80:
KIR2DL1 recognizes the group of HLA-C molecules
with a Lys80 residue (HLA-C2 specificity), whereas the
KIR2DL2 and KIR2DL3 allelic forms recognize the group
of HLA-C with an Asn80 residue (HLA-C1 specificity).
Regarding inhibitory KIR3D, KIR3DL1 interacts with
Bw4-containing HLA-B alleles, and KIR3DL2 has been
reported to recognize HLA-A3 and HLA-A11 allotypes
(Parham, 2005). In addition, the CD94-NKG2A hetero-
dimers recognize the nonclassical MHC class I molecule
HLA-E in humans and Qa1 in the mouse (Natarajan et al.,
2002).
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of MHC class I molecules, i.e., ‘‘missing self’’ (Ljunggren
and Karre, 1990), NK cells are no longer subject to inhib-
itory signals initiated by the engagement of MHC class
I-specific receptors, promoting NK cell cytotoxicity and
cytokine production. Interaction between MHC class I
and their inhibitory receptors is thus thought to play
a major role in the mechanisms of self tolerance during
NK cell effector phases. Along this line, it has been
reported that all mature NK cells express at least one
self MHC class I-specific inhibitory NK cell receptor
(the ‘‘at least one rule’’), ensuring NK cell tolerance to
self (Valiante et al., 1997). As KIR, Ly49, and their cog-
nate MHC class I ligands are encoded by distinct chro-
mosomes, this hypothesis implies mechanisms that
would positively select NK cells expressing a self MHC
class I-specific inhibitory receptor and/or negatively
select NK cells lacking expression of a self MHC class
I-specific inhibitory receptor.
A number of experiments in the mouse have clearly
established the role of MHC class I to render NK cells
functional (Dorfman and Raulet, 1996; Olsson et al.,
1995). In particular, there is a correlation between the
presence of H-2Dd and the function of the NK cell subset
expressing its inhibitory receptor Ly49A (Olsson et al.,
1995). These issues have been recently revisited show-
ing that NK cells lacking self MHC class I-specific inhib-
itory receptor are present in the mouse as a hyporespon-
sive subset (Fernandez et al., 2005) and that engagement
of inhibitory Ly49 molecules by self MHC class I molecule
‘‘licenses’’ NK cells to become functionally competent
(Kim et al., 2005).
In humans, studies performed with peripheral blood
NK cells from MHC class I-deficient individuals (patients
with transporters associated with antigen processing
[TAP] deficiency) have also shown an influence of MHC
class I on the acquisition of NK cell function: NK cells
from TAP-deficient patients exhibit an activation defect
(Furukawa et al., 1999; Vitale et al., 2002; Zimmer et al.,
1998). However, how MHC class I participate in the shap-
ing of human NK cell function remains unknown (Yo-
koyama and Kim, 2006; Raulet and Vance, 2006). Here
we address whether human NK cells are educated de-
pendent upon the inhibitory MHC class I receptors they
express. Our results show that the recognition of self
MHC class I by inhibitory KIR is involved in the calibration
of NK cell effector capacities during a developmental
stage, allowing the subsequent recognition of the ab-
sence of self MHC class I during interaction with target
cells.
Results
Characterization of Functional NK Cells in Human
Peripheral Blood
The lack of reliable detection protocol for cytolytic ver-
sus noncytolytic subsets within a complex cell popula-
tion hampered the precise characterization of ‘‘naturally
occurring’’ killer NK cells in unmanipulated samples. In
contrast to the standard Cr51 release assay that mea-
sures total target cell death, cytotoxic function can be
assessed by flow cytometry via the cell-surface mobili-
zation of CD107 (LAMP), a marker of intracytoplasmic
cytolytic granules, as an indication of effector cell de-granulation (Bryceson et al., 2005; Rubio et al., 2003;
Wolint et al., 2004). The CD107 assay correlates with
the Cr51 release assay: NK-resistant targets do not in-
duce CD107 cell-surface mobilization, whereas anti-
body-coated cells (antibody-dependent cell cytotoxicity
[ADCC]) and sensitive MHC class I2 cells do (data not
shown). This assay allowed us to identify ‘‘naturally oc-
curring’’ killer NK cells in freshly isolated human periph-
eral blood samples and to compare this cytolytic poten-
tial with IFN-g production in a multiparameter flow
cytometric analysis. We first focused on NK cell stimula-
tion by the erythroleukemic cell line K562, as a prototyp-
ical example of a MHC class I-deficient tumor cell target.
Heterogeneity among three activated NK cell subsets,
CD107+IFN-g2, CD107+IFN-g+, and CD1072IFN-g+ NK
cells, could be documented upon K562 stimulation
(Figure 1A, left), indicating that only a subset of human
peripheral blood NK cells (14.0% 6 1.0%, n = 9) acts
as steady-state killer cells in this assay and that NK
cell cytotoxic function and cytokine secretion can occur
in the same cells but do not precisely correlate.
We next documented the phenotype of cytolytic and
IFN-g-producing NK cells by using a panel of monoclonal
antibodies (mAb) reacting with NK cells. It has been pro-
posed that the density of CD56 (neural cell adhesion
Figure 1. A Multiparameter Flow Cytometric Assay Reveals the
Presence of NK Cell Subsets with Various Functional Capacities
(A) PBMC preparations were incubated in the presence or absence
of K562 cells for 4 hr at an effector:target ratio of 5:1. Samples were
analyzed by flow cytometry and gated on NK cells (CD32CD56+ lym-
phocytes). Dot plots of one representative experiment of nine are
represented. Numbers indicate the mean percentages of NK cells
in each quadrant.
(B) PBMC preparations were incubated as in (A) but in the presence
of antibody-coated target cells (P815), IL-12 (20 ng/mL), or IL-15 (10
ng/mL). Dot plots of one representative experiment of nine are rep-
resented. Numbers indicate the percentages of NK cells in each
quadrant.
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333molecule, 140 kDa isoform) at the NK cell surface dis-
criminates between two functionally distinct NK cell sub-
sets: cytolytic CD56dim NK cells and cytokine-producing
CD56bright NK cells (Cooper et al., 2001). In contrast,
K562 stimulation induces IFN-g production mainly by
CD56dim NK cells, whereas IFN-g production by
CD56bright NK cells is marginal (Figure 1A, right). Similar
results were observed for tumor necrosis factor-a secre-
tion (data not shown). Stimulation of freshly isolated NK
cells by ADCC by antibody-coated P815 mouse masto-
cytoma cells yielded comparable results as by K562
stimulation (Figure 1B). NK cell treatment with IL-12 or
IL-15 for 4 hr primarily resulted in IFN-g secretion, but
not in CD107 cell-surface mobilization (Figure 1B).
When NK cells were stimulated with these cytokines, a
higher fraction of IFN-g-producing NK cells was included
in the CD56bright NK cell fraction (Figure 1B), more con-
sistent with previous distinction between CD56dim and
CD56bright NK cells (Cooper et al., 2001). In conclusion,
only a minor fraction of freshly isolated peripheral blood
NK cells are reactive with MHC class I-deficient tumor
cells (K562), antibody-coated target cells, IL-12, or IL-
15 in a 4 hr assay, and the dichotomy between cytolytic
CD56dim NK cells and cytokine-producing CD56bright
NK cells does not apply when freshly isolated NK cells
were stimulated with tumor cells.
NK Cells Lacking MHC Class I-Specific Cell-Surface
Receptors Are Hyporesponsive
In an attempt to characterize the subset of freshly iso-
lated peripheral NK cells that are reactive with K562, an-
tibody-coated target cells, or cytokines, we analyzed
the expression of a large panel of molecules on the sur-
face of CD107+ or IFN-g+ NK cells. In particular, the
recent findings that mouse NK cell activity was corre-
lated to the cell-surface expression of receptors for
MHC class I prompted us to directly address this issue
in humans (Fernandez et al., 2005; Kim et al., 2005).
We distinguished two reciprocal NK cell subsets:
KIR2NKG2A2 NK cells, which do not express KIR2DL1,
KIR2DS1, KIR2DL2, KIR2DL3, KIR2DS2, KIR2DS4,
KIR3DL1, or CD94-NKG2A, and KIR+NKG2A+ NK cells,
which express at least one of these receptors. Upon en-
counter with K562, KIR+NKG2A+ NK cells contain on av-
erage twice as much CD107+ and IFN-g+ cells than do
KIR2NKG2A2 NK cells (Figure 2A). No modification of
KIR or NKG2A NK cell-surface phenotype could be ob-
served upon 4 hr incubation with target cells (data not
shown). Thus, healthy individuals have a substantial
fraction of circulating NK cells that lack the MHC class
I-specific receptors KIR and NKG2A (13% 6 6% of
peripheral blood NK cells, Figure 2B) and exhibit damp-
ened cytolytic and cytokine production ability upon
interaction with the MHC class I-deficient target cell
K562. Because of the differential surface expression of
KIR and NKG2A between CD56dim and CD56bright NK
cells (Andre et al., 2000; Cooper et al., 2001), we further
compared the functional properties of more restricted
and similar NK cell subsets by gating out CD56bright NK
cells from our analysis. Consistent with data in Figure 2A,
CD56dimKIR2NKG2A2 NK cells are hyporesponsive to
K562 for both CD107 and IFN-g induction as compared
to CD56dimKIR+NKG2A+ NK cells (Figure 2C). The ab-
sence MHC class I molecules on the surface of K562cells rules out the possibility that other inhibitory recep-
tors for MHC class I molecules are involved in the weak
effector function of CD56dimKIR2NKG2A2 NK cells.
Importantly, the latter were also poorly reactive to anti-
body-coated target cells (ADCC, Figure 2D). Besides
MHC class I-specific receptors, a large variety of inhibi-
tory cell-surface molecules has been described (Daeron
and Vivier, 1999; Ravetch and Lanier, 2000), suggesting
that the hyporesponsiveness of CD56dimKIR2NKG2A2
NK cells might result from the engagement of unknown
inhibitory receptors that sense ligands on both human
K562 cells and mouse P815 cells. However, this hypoth-
esis was ruled out by the demonstration that
CD56dimKIR2NKG2A2 NK cells are also less responsive
than CD56dimKIR+NKG2A+ NK cells when stimulated
with plate bound CD16 mAb, a cell-free stimulus
(Figure 2D). Similar conclusions were drawn when
KIR2NKG2A2 and KIR+NKG2A+ NK cells were com-
pared independently of their expression of CD56 (data
not shown).
Mechanisms of KIR2NKG2A2 NK Cell
Hyporesponsiveness
The hyporesponsiveness of KIR2NKG2A2 as compared
to KIR+NKG2A+ NK cells prompted us to consider the
possibility that KIR2NKG2A2 cells were not mature NK
cells or even not bona fide NK cells. In addition to their
CD32CD56+ cell-surface phenotype, KIR2NKG2A2 NK
cells were similar to mature KIR+NKG2A+ NK cells, as
judged by their intracellular content in granzyme B and
perforin (Figure 3A). PEN5 (CD162R), a specific marker
of mature NK cells in peripheral blood (Andre et al.,
2000), was also expressed on KIR2NKG2A2 and
KIR+NKG2A+ NK cells at comparable amounts (Figure 3).
The only three noticeable differences between the cell-
surface phenotype of KIR2NKG2A2 and KIR+NKG2A+
NK cells reside in the reduced cell-surface expression
of CD94 and CD226 (DNAM-1), as well as the reduced
size of the CD56bright subset within KIR2NKG2A2 NK
cells. However, KIR2NKG2A2 were undistinguishable
from KIR+NKG2A+ NK cells on the basis of the cell-
surface expression of 16 other cell-surface receptors
including the natural cytotoxicity receptors (NKp30,
NKp46, NKp44), NKG2D, CD8a, CD2, CD85j (ILT-2,
LIR-1), CD244 (2B4) CD11b, and CD11c (Figure 3).
Importantly, CD16 is expressed at similar surface
levels between KIR2NKG2A2 and KIR+NKG2A+ NK
cells, despite the dampened CD16-dependent cytolytic
and cytokine production in KIR2NKG2A2 NK cells
(i.e., ADCC or CD16 mAb-coated plates, Figure 2D).
Of note, the IFN-g production in response to PMA
and ionomycin stimulation was comparable between
KIR2NKG2A2 and KIR+NKG2A+ NK cells, over all PMA
concentrations tested (Figure 4A and data not shown).
We next analyzed the production of IFN-g by these
two reciprocal NK cell subsets in response to cytokines.
Although KIR2NKG2A2 NK cells produce IFN-g upon
treatment with IL-12 and IL-18, their response was lower
than that of KIR+NKG2A+ NK cells (Figure 4B). Short
treatment with cytokines can also prime NK cell cytotox-
icity. In particular, the MHC class I2 B lymphoblastoid
cells L721.221 are resistant to freshly isolated NK cells
but sensitive to cytokine-activated NK cells. We there-
fore tested whether cytokine treatment arms both
Immunity
334Figure 2. NK Cells Lacking Surface HLA Class I Receptors Are Hyporesponsive to Tumor Cells and CD16 mAb-Coated Plates
(A) Two reciprocal cell subsets were defined within peripheral blood NK cells: KIR2NKG2A2 NK cells that do not express KIR2DL1, KIR2DS1,
KIR2DL2, KIR2DS2, KIR2DS4, KIR3DL1, or NKG2A, and KIR+NKG2A+ NK cells that express at least one of these receptors. PBMC preparations
were incubated as in Figure 1A. Dot plots of one representative experiment of nine are represented. Numbers indicate the mean percentages6
SD of NK cells in each quadrant (n = 9).
(B) PBMC preparations were stained with CD3 and CD56 mAb to define NK cells. KIR and NKG2A expression was assessed with a mixture of KIR
and NKG2A mAb as in (A). Histograms of one representative experiment of nine are represented. Numbers indicate the mean percentages6 SD
of NK cells (n = 9) in corresponding areas.
(C) PBMC preparations were stained with CD3 and CD56 mAb to define NK cells. KIR and NKG2A expression was assessed with a mixture of KIR
and NKG2A mAb as in (A). CD56bright NK cells were gated out. PBMC preparations were incubated with K562 cells for 4 hr. Results indicate the
percentage of reactive NK cells within each NK subset (n = 17). ***p < 0.001. Each dot and line represents the results from one individual. Open
symbols correspond to KIR2NKG2A2 NK cells; closed symbols correspond to the NK cell subset expressing a least one of these MHC class I
receptors (KIR+NKG2A+).
(D) As in (C), but PBMC preparations were incubated with antibody-coated P815 cells (ADCC) or plate bound CD16 mAb for 4 hr. Results indicate
the percentage of reactive NK cells within each NK subset (n = 8); **p < 0.01; ***p < 0.001.KIR2NKG2A2 and KIR+NKG2A+ NK cells and abolishes
their functional differences. Upon 24 hr incubation in
the presence of IL-15 or IL-12 and IL-18 followed by
a 4 hr encounter with L721.221 cells, KIR2NKG2A2 NK
cells were again less potent than KIR+NKG2A+ NK cells
for both cytotoxicity and IFN-g production (Figure 4C).
CD56bright NK cells were gated out from these analyses(Figures 4B and 4C) to more precisely compare
KIR2NKG2A2 and KIR+NKG2A+ NK cells, but similar
data were obtained when CD56bright were included in
the analysis (data not shown). Thus, the functional differ-
ence between KIR2NKG2A2 and KIR+NKG2A+ NK cells
may affect a common signaling element downstream
of various NK cell-activating pathways (including but
NK Cell Education by HLA Class I Receptors
335Figure 3. Phenotype of Hyporesponsive KIR2NKG2A2 NK Cells
PBMC preparations were stained as in Figure 2A.
Samples were analyzed for the cell-surface expression of indicated cell-surface molecules by flow cytometry. Numbers indicate the % of NK
cells in corresponding areas, or the total mean fluorescence intensity for perforin, granzyme B, NKp30, NKp46, CD244, and CD226. Histograms
of one representative experiment of three are represented.not only ITAM-dependent pathways) and upstream of
transcription factors’ activation.
Impact of Inhibitory KIR and Cognate MHC Class I
on NK Cell Function
As IL-15 and IL-12 + IL-18 were unable to abolish the low
responsive state of KIR2NKG2A2 NK cells against MHC
class I-deficient target cells, we tested other potential
recovery signals. It is striking that freshly isolated
KIR2NKG2A2NK cells have features shared with freshly
isolated NK cells from HLA class I-deficient individuals,
including defects in K562 killing and ADCC (Furukawa
et al., 1999; Zimmer et al., 1998). The lack of receptors
(KIR and NKG2A) in one case and the lack of ligands(MHC class I molecules) in the other thus leads to similar
human NK cell phenotypes. We therefore directly tested
whether MHC class I influences the responsive capacity
of NK cells bearing cognate or noncognate NK cell re-
ceptors and limited our analysis to KIR by gating out
NKG2A+ NK cells. The extreme polymorphism of both
HLA class I and KIR loci in the human population (Par-
ham, 2005) required us to design our study at the molec-
ular level, taking into account the genotypes of our co-
hort of healthy donors at these loci. We selected
individuals that express both a restricted subgroup of
HLA-C alleles and the cognate inhibitory KIR gene. A
first group of individuals was thus selected on the basis
of the homozygous expression of the C2 group ofHLA-C
Immunity
336Figure 4. Characterization of Hyporesponsive KIR2NKG2A2 NK Cells
(A) PBMC preparations were incubated in the presence or absence of PMA (1 ng/mL) and ionomycin (0.5 mM) for 4 hr. Histograms indicate the
mean percentages 6 SD of reactive NK cells within each NK subset (n = 7).
(B) As in Figure 2C, but PBMC preparations were incubated for 24 hr with IL-12 (5 ng/mL) and IL-18 (20 ng/mL) in combination. Results indicate
the mean percentages 6 SD of reactive NK cells within each NK subset (n = 5); *p < 0.05.
(C) As in Figure 2C, but PBMC preparations were incubated for 24 hr with IL-15 (10 ng/mL) or IL-12 (5 ng/mL) and IL-18 (20 ng/mL) in combination.
Cells were washed and incubated for an extra 4 hr with L721.221 cells. Histograms indicate the mean percentage 6 SD of reactive cells within
each NK subset (n = 5). *p < 0.05; **p < 0.01.alleles (HLA-C2) and the presence of the KIR2DL1 gene
that encodes the inhibitory KIR recognizing HLA-C2
molecules (Figure 5A). In these individuals, we analyzed
the reactivity of NK cells that express KIR2DL1 in the
absence of other MHC class I receptors (KIR and
NKG2A, referred as to KIR2DL1+others2 NK cells). For
each sample, we compared these results to that ob-
tained for the ‘‘reciprocal’’ subset of NK cells, i.e., NK
cells that express a single KIR (product of the KIR2DL2
gene) that does not interact with HLA-C2 (referred as
to KIR2DL2+others2 NK cells). The effector function of
KIR2NKG2A2 NK cells was also analyzed as a hypores-
ponsive control for each sample. KIR2DL1+others2 NK
cells were fully competent for IFN-g production and
CD107 mobilization in response to trigger by K562,
ADCC, and CD16 mAb-coated plates (Figures 5B and
5C). In marked contrast, both KIR2DL2+others2 and
KIR2NKG2A2 NK cells were hyporesponsive to the
very same stimuli in the same donor (Figures 5B and
5C). These results indicate that the expression of an
inhibitory KIR at the NK cell surface is not sufficient
to abolish the hyporesponsiveness detected in
KIR2NKG2A2 NK cells and that the presence of a HLA
class I ligand for the inhibitory KIR in the individual is
necessary to remove NK cell hyporesponsiveness.
If this model was correct, one could predict that the
KIR2DL1+others2 NK cell subset would be hyporespon-
sive in individuals in which KIR2DL1 has no cognate
HLA-C2 ligand. We directly tested this hypothesis by
analyzing a second cohort of individuals, who were se-
lected for the homozygous expression of the C1 group
of HLA-C alleles (HLA-C1) and the presence of the
KIR2DL2 gene that encodes for the inhibitory KIR recog-
nizing HLA-C1 molecules (Figure 6A). In these individ-
uals, KIR2DL1+others2 NK cells were hyporesponsive
for all stimuli, the same way as KIR2NKG2A2 NK cells
(Figures 6B and 6C). In contrast, KIR2DL2+others2 NK
cells were competent in the same donors (Figures 6B
and 6C). Most mAb recognizing KIR are crossreactive
with inhibitory KIR-L and their activating KIR-S counter-
parts as a result of the extreme homology between thesemolecules (Stewart et al., 2005). All the above data were
obtained with KIR genotyped individuals, in which we
could unambiguously infer the KIR2DL1 NK cell-surface
phenotype to inhibitory KIR2DL1 alleles and the
KIR2DL2 NK cell-surface phenotype to inhibitory
KIR2DL2 alleles. Similar data were obtained with individ-
uals bearing activating KIR2DS1 or KIR2DS2 genes
(data not shown) as well as with individuals that are de-
ficient in all activating KIR genes but KIR2DS4 (A haplo-
type donors) (see Figure S1 in the Supplemental Data
available with this article online). These results suggest
that activating KIR do not play a critical role in NK cell
education, consistent with the absence of NK cell phe-
notype in KIR-S-deficient individuals (Parham, 2005),
as well as in mice that are deficient for all activating
Ly49-dependent signals (i.e., KARAP(DAP12)-deficient
mice) (Bakker et al., 2000; Tomasello et al., 2000). As ex-
pected from a NK cell education process that depends
upon the interaction between inhibitory KIR and self
HLA, the competence of KIR2DL1+others2 NK cells in
C2C2 individuals and of KIR2DL2+others2 NK cells in
C1C1 individuals is stable with time. This was observed
when NK cells were stimulated with antibody-coated
targets and IFN-g production was measured (Figure S2).
Similar results were obtained with the use of CD107
mobilization as a read-out and K562 as well as CD16
mAb-coated plates as stimuli (data not shown).
Thus, peripheral blood NK cells expressing an inhibi-
tory KIR-recognizing self HLA class I were functionally
reactive to various MHC class I-deficient stimulation
(i.e., target cells and mAb-coated plates). In contrast,
NK cells expressing no inhibitory KIR or NKG2A (Figure 2)
or expressing inhibitory KIR that do not interact with self
MHC class I molecules (Figure 4) were hyporesponsive
to the same stimuli. An important prediction derived
from this model is that the KIR2DL1+other2 and the
KIR2DL2+other2 NK cell subsets would be equally re-
sponsive when isolated from C1C2 heterozygous indi-
viduals. Stimulation of freshly isolated C1C2 PBMC
with plate bound CD16 mAb indicates that this was
indeed the case (Table 1).
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337Figure 5. Evidence for a Role of Inhibitory KIR and HLA Class I in the Acquisition of NK Cell Function in C2C2 Individuals
(A) Top: The KIR genotype (kirotype) of a representative C2C2 KIR2DL1+ donor. Bottom: Gating of the indicated NK cell subsets.
(B) PBMC preparations were incubated for 4 hr in the presence of indicated stimuli and analyzed by 6-color flow cytometry. The bars indicate the
% of CD107+ or IFN-g+ cells in the indicated NK cell subsets. The bars corresponding to the NK cell subset that expresses a KIR interacting with
self HLA class I are in black. The bars corresponding to the NK cell subset that does not express NKG2A or a KIR interacting with self HLA class I
are in white. A representative experiment of seven performed with six other C2C2 individuals is shown.
(C) As in (B) for a group of C2C2 donors (n = 7 for K562 stimulation; n = 5 for ADCC and CD16 stimulation), including three donors with no 2DS1 and
2DS2 genes. Each dot and line represents the results from one individual. Open symbols correspond to the NK cell subsets that do not express
NKG2A or a KIR interacting with self HLA class I. Closed symbols correspond to the NK cell subset expressing a KIR interacting with self HLA
class I.
Immunity
338Figure 6. Evidence for a Role of Inhibitory KIR and HLA Class I in the Acquisition of NK Cell Function in C1C1 Individuals
(A) Top: The KIR genotype (kirotype) of a representative C1C1 KIR2DL2+ donor. Bottom: Gating of the indicated NK cell subsets.
(B) PBMC preparations were incubated for 4 hr in the presence of indicated stimuli and analyzed by 6-color flow cytometry. The bars indicate
the % of CD107+ or IFN-g+ cells in the indicated NK cell subsets. The bars corresponding to the NK cell subset that expresses a KIR interacting
with self HLA class I are in black. The bars corresponding to the NK cell subset that does not express NKG2A or a KIR interacting with self HLA
class I are in white. A representative experiment of seven performed with six other C1C1 individuals is shown.
(C) As in Figure 5B for a group of C1C1 donors (n = 7 for K562 stimulation; n = 5 for ADCC and CD16 stimulation), including three donors with no
2DS1 and 2DS2 genes. Each dot and line represents the results from one individual. Open symbols correspond to the NK cell subsets that do not
express NKG2A or a KIR interacting with self HLA class I. Closed symbols correspond to the NK cell subset expressing a KIR interacting with self
HLA class I.Discussion
These studies were originally set up to precisely define
the subset of circulating NK cells that exert a naturallyoccurring cytotoxic function. It has been previously
shown that human NK cells can be divided in two func-
tionally distinct subsets: CD56dim and CD56bright NK
cells. These NK cell populations differ in their trafficking
NK Cell Education by HLA Class I Receptors
339properties, the CD56bright NK cells having a greater num-
ber in lymphoid organs than the CD56dim NK cells, and
the latter being the most prominent subset in blood (Fer-
lazzo and Munz, 2004). The CD56dim NK cell population is
also reported as being more prone to cytotoxicity and
the CD56bright subset being more prone to produce cyto-
kines such as IFN-g (Cooper et al., 2001). By using freshly
isolated human peripheral blood mononuclear cell prep-
arations and a multiparameter flow cytometric assay, we
show that most, if not all, NK cells that are cytolytic and/
or produce IFN-g upon K562 or antibody-coated target
stimulation belong to the CD56dim subset, whereas NK
cells that readily respond to IL-12 or IL-15 belong to
the CD56bright NK cell subset. It appears therefore
more operational to define CD56dim and CD56bright NK
cell subsets as ‘‘target cell responsive’’ and ‘‘cytokine
responsive,’’ respectively. Thus, the functional hetero-
geneity of human peripheral blood NK cells is more com-
plex than a simple ‘‘cytolytic versus cytokine producing’’
dichotomy, underscoring the plasticity of NK cell re-
sponses to various stimuli.
In our search for correlates between NK cell pheno-
type and reactivity to tumor cells, we found that the
cell-surface expression of MHC class I receptors was
the most divergent difference between responsive and
hyporesponsive NK cells. Indeed, the KIR+NKG2A+ NK
cells contain most of CD107+ and IFN-g+ NK cells upon
stimulation with MHC class I2 tumor targets, and also
to some extent upon stimulation with cytokines. These
results raise a number of issues related to NK cell educa-
tion and tolerance to self. It has been indeed proposed
that each NK cell clone expresses at least one self
MHC class I-specific inhibitory receptor, ensuring NK
cell tolerance to self (Valiante et al., 1997). However, we
show here that a substantial subset of KIR2NKG2A2
NK cells is present in freshly isolated peripheral blood
from normal individuals. Regardless of the imprecision
in defining KIR genes, pseudogenes, and alleles, at least
13KIR genes can be expressed as proteins in the human
population (Parham, 2005). The paucity of available KIR
mAb thus represents a limit in our study and prevents
us from formally concluding that the NK cells that we de-
fine as KIR2 do not express any inhibitory KIR (e.g.,
KIR3DL3, KIR2DL5). Despite this caveat, previous re-
sults with NK cell clones and supporting the ‘‘at least
one rule’’ were obtained with a set of mAb comparable
to that used in our study (Valiante et al., 1997). It is thus
Table 1. Function of NK Cell Subsets in HLA-C1C2 Heterozygote
Individuals
% IFN-g+ Cells
Donors KIR2NKG2A2 KIR2DL1+others2 KIR2DL2+others2
#7401 9.5 22 19.4
#7400 8.7 15.5 14.9
#6682 4 8.4 9.7
#6434 24.1 34.5 32.1
#7430 19 32 32.5
PBMC preparations isolated from five representative C1C2 donors
were stimulated for 4 hr with plate bound CD16 mAb. Cells were
stained as indicated in Experimental Procedures. Results indicate
the percentage of IFN-g-producing cells within the KIR2NKG2A2,
KIR2DL1+others2, and KIR2DL2+others2 NK cell subsets.possible that KIR2NKG2A2NK cells are counterselected
by NK cloning procedures, suggesting a difference in the
survival and/or proliferation requirements between
KIR2NKG2A2 and KIR+NKG2A+ NK cells.
With KIR and HLA genotyping, our results strongly
support that NK cells are not fully reactive against
MHC class I-deficient stimuli unless their inhibitory re-
ceptors have recognized self MHC class I molecules
prior to encounter with these stimuli. Taking into account
the documented interaction between KIR and HLA, the
similarity of reduced responsiveness seen on one hand
in KIR2NKG2A2 NK cells as well as in KIR+NKG2A2 NK
cells that do not interact with self MHC class I, and on
the other hand in KIR+ cells in MHC class I-deficient indi-
viduals (Furukawa et al., 1999; Vitale et al., 2002; Zimmer
et al., 1998), is a strong argument to propose that NK
cells must encounter self class I to become fully reactive.
Similar data have been obtained in the mouse, where
freshly isolated NK cells that lack the cell-surface ex-
pression of inhibitory receptors for self MHC class I
were hyporesponsive to various stimulations, including
NKRP1 or NKG2D mAb, and MHC class I-deficient tar-
gets (Fernandez et al., 2005; Kim et al., 2005). To explain
these data, it has been proposed that the engagement
of inhibitory receptors with self MHC class I provides
a positive signal during NK cell maturation that would
lead to the ‘‘licensing’’ of fully competent peripheral NK
cells (Kim et al., 2005). This model implies opposite sig-
naling capacities of inhibitory MHC class I receptors
according to the stage of NK cell development: positive
signaling during maturation and negative signaling dur-
ing effector function. At present, we cannot formally
rule out this model, which is compatible with our data.
Importantly, NK cells that fail to engage MHC class I-
specific inhibitory receptors (i.e., KIR2NKG2A2 NK cells
and KIR+NKG2A2 NK cells that do not interact with self
MHC class I) are bona fide NK cells with a number of fea-
tures compatible with NK cell effector capacity, such as
intact cell-surface phenotype, perforin and granzyme
content, as well as potent reactivity to stimuli that by-
pass cell-surface receptors (PMA and ionomycin). Yet
these cells are hyporesponsive to a number of stimuli,
such as K562 cells, which are recognized by a combina-
tion of NK cell receptors including NKp30, L721.221 cells
that are recognized by NKp46, 2B4, NTBA, and CD2 (A.
Moretta, personal communication), immunoglobulin-
coated mouse mastocytoma P815 cells (ADCC), as
well as IL-12 and IL-18 to a lesser extent. One mecha-
nism that could explain this broad hyporesponsiveness
is that these cells express an inhibitory receptor, which
is not specific for MHC class I. However, this possibility
would be hard to reconcile with their hyporesponsive-
ness in our cell-free stimulation assay (CD16 mAb-
coated plates), unless the inhibitory receptor would
signal in absence of ligands or if the ligand would be
expressed on NK cells themselves. Therefore, the sim-
plest explanation to our findings rather is that the effect
of KIR-MHC class I interaction on NK cell development
operates at a common signaling element downstream
of various NK cell-activating pathways (including but
not only ITAM-dependent pathways) and upstream of
transcription factors’ activation. Consequently, the acti-
vating transduction circuits would be calibrated during
NK cell maturation, and this calibration would integrate
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maturation in the context of inhibitory signals would re-
sult in setting more efficient activating signaling circuits
than in absence of inhibitory receptor ligation. In which
anatomical sites and when such educating impact of
KIR-MHC class I interaction takes place remains to be
defined. This ‘‘calibration model’’ favors an earlier hy-
pothesis based on the crosstalks between activating
and inhibitory pathways during NK cell development
(Fernandez et al., 2005). According to this report, NK
cell maturation would be driven by some still-unknown
receptors whose activating signals would lead to NK
cell hyporesponsiveness unless the engagement of in-
hibitory receptors with self MHC class I attenuate these
signals, allowing the export of fully competent NK cells
(Fernandez et al., 2005; Raulet and Vance, 2006). Calibra-
tion is a constant theme in the selection of T and B lym-
phocytes (Fischer and Malissen, 1998), which could thus
be extended to NK cells. It is also important to note that
a very large fraction of NK cells that are KIR+NKG2A+ do
not respond to classical NK cell stimulation (e.g., K562,
ADCC, CD16 mAb-coated plates). We do not believe
that this is purely because these cells have no self-spe-
cific MHC class I receptor, since only 5%–30% of NK cell
expressing a self-specific MHC class I receptor are ca-
pable of functional reactivity with K562. This lack of re-
sponse is also not due to limitations of the test and a pla-
teau of detection, because PMA and ionomycin induce
IFN-g production by more than 75% of resting NK cells,
and IL-2-activated NK cells contain up to 80% CD107+
and IFN-g+ cells in the standard 4 hr K562 stimulation
(data not shown). Other factors thus also contribute to
NK cell reactivity in addition to MHC class I-driven
education. Along this line, IL-12 could be one of these
factors, as indicated by the fact that NK cells from IL-
12RB1-deficient patients are hyporesponsive to in vitro
stimulation by K562 (unpublished data).
What could be the biological relevance of the calibra-
tion of NK cell-activating pathways by the recognition of
self MHC class I molecules via inhibitory receptors? NK
cells from MHC class I-sufficient individuals and mice
kill MHC class I-deficient targets, according to the
‘‘missing self’’ recognition. In contrast, NK cells from
MHC class I-deficient individuals and mice are tolerant
to self, as shown by the fact that they do not kill the
very same MHC class I-deficient targets (Furukawa
et al., 1999; Ljunggren and Karre, 1990; Raulet et al.,
2001; Vitale et al., 2002; Zimmer et al., 1998). However,
NK cells from MHC class I-deficient mice are fully protec-
tive against mouse cytomegalovirus infection (Tay et al.,
1995). We thus propose that NK cell education on self
MHC class I by inhibitory receptors does not result in
a global anergy versus competence fate, but rather se-
lectively allows NK cells to discriminate between cells
expressing normal levels of MHC class I and cells with
downregulated MHC class I expression, i.e., ‘‘missing
self’’ recognition. Indeed, NK cell maturation in the
context of inhibitory KIR or Ly49 ligation would increase
the potential of activating signaling circuits. NK cell acti-
vation pathways would thus be fully activable upon sub-
sequent encounter with MHC class Idim/2 cells. In addi-
tion, it has been very recently reported that HLA class I
ligands increase the frequencies of NK cells expressing
cognate KIR (Yawata et al., 2006).These data might be considered for the development
of our understanding of autoimmunity and in the applica-
tion of immune-based therapies. In particular, genetic
epidemiologic studies have revealed a role for KIR and
HLA in the susceptibility or resistance to a variety of pa-
thologies, including autoimmune syndromes, cancer,
and infectious diseases (Carrington and Martin, 2006).
The current interpretation of these associations relies
on the role of KIR-HLA interaction in the modulation of
NK cell effector function during interaction with target
cells. The present results suggest that the association
between KIR, HLA, and human disease might also be
the consequence of the role of KIR-HLA in NK cell educa-
tion. Similarly, pioneering results have shown that donor
versus recipient NK cell alloreactivity could eliminate
leukemia relapse and graft rejection, while protecting
patients against graft versus host disease (Ruggeri
et al., 2002). During the first months post-hematopoietic
transplant, donor NK cells develop in the recipient just as
they would develop in the donor (Parham, 2005), becom-
ing potentially alloreactive to the hosts. Our data intro-
duce the possibility that these NK cells would rather be
hyporesponsive, if they do not find proper educating
MHC class I impact in the recipient. This scenario may
be highly dependent upon the recipient’s conditioning
regimen as well as the dose of donor hematopoietic
progenitors (i.e., the likelihood of interaction with donor
or recipient MHC class I molecules), providing a rational
basis for the variable outcome of these MHC-
mismatched hematopoietic transplantation protocols
(Parham, 2005).
Finally, it is most likely that other inhibitory receptors
expressed by NK cells contribute to their education
through MHC class I-dependent or -independent mech-
anisms. Education through other receptors would hide
the apparent effect of KIR-MHC class I education, sug-
gesting that the impact of this education is larger than
we can directly demonstrate. In particular, this hypothe-
sis would explain the residual activity in KIR2NKG2A2
NK cells and in KIR+NKG2A2NK cells that do not interact
with self MHC class I. Despite this possibility, it is re-
markable that a role for the inhibitory KIR remains appar-
ent, showing a dominant role for these molecules at the
whole NK cell population level. More generally, a variety
of other inhibitory receptors have been described on he-
matopoietic cells, several of them being expressed at
early stages of cell differentiation (Daeron and Vivier,
1999; Long, 1999; Ravetch and Lanier, 2000). Thus, inhib-
itory receptors, other than MHC class I-specific recep-
tors, might also educate a wider array of hematopoietic
cells to discriminate between interacting cells that do,
or do not, express self ligands.
Experimental Procedures
Cells and Patients
Peripheral blood mononuclear cells (PBMC) were isolated by Ficoll-
Hypaque density gradient centrifugation (Amersham Pharmacia
Biotech) from whole-blood samples obtained from normal healthy
volunteer donors, according to the local ethics committees on hu-
man experimentations (Mu¨nchen, Marseille).
CD107 Mobilization Assay
Natural cytotoxicity was assessed with the MHC class I2 human
erythroleukemic K562 target cells, and ADCC was assessed with
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341the P815 mouse mastocytoma cells coated with rabbit anti-mouse
lymphocyte antibodies (Accurate Biochemicals). NK cells were
tested for their cytolytic potential with the CD107 mobilization assay.
In this test, FITC-CD107 mAb was added to the effector and target
cell mixtures during a 4 hr incubation. FITC+ cells were then scored
by flow cytometry, revealing cells that have undergone granule-
mediated cytotoxicity. Monensin was added during the assay to
prevent the acidification of the endosomal compartment, which
could alter the fluorescence of internalized CD107:FITC-CD107 mAb
complexes (Rubio et al., 2003).
Cell Stimulation
For CD16 stimulation, F(ab)’2 goat anti-mouse IgG (Immunotech)
was coated to plastic wells for 2 hr in PBS at 37C at 20 mg/mL. After
washes, mouse CD16 mAb (Pharmingen) was incubated for 30 min
at 4C at 10 mg/mL in PBS. After washes, 5.106 PBMC were plated
in each well in the presence of CD107 mAb and monensin as de-
scribed in the next section.
mAb and Flow Cytometric Analysis
The following mouse mAb were used: APC-Cy7, APC-CD3 (SK7),
APC-CD3 (UCHT1), APC-CD11c (B-Ly6), PE-Cy5-CD107a (H4A3),
FITC-CD107a (H4A3), FITC-CD107b (H4B4), FITC-CD85j (GHI/75),
FITC-CD20 (2H7), FITC-CD40 (5C3), and FITC-MHC class II (Tu¨39)
(Becton Dickinson); and FITC-CD11b (BEAR1), FITC-CD16 (3G8),
FITC-CD95 (UB2), FITC-CD83 (HB15a), PE-Cy7-CD56 (N901), PE-
NKG2D (ON72), PE-NKp30 (Z25), PE-NKp46 (Bab281), PE-CD94
(HP-3B1), PE-NKG2A (Z199), PE-KIR2DL1/S1 (EB6), PE-KIR2DL2/
L3/S2 (GL183), PE-KIR3DL1 (Z27), and PE-KIR2DS4 (FES172) (Beck-
man Coulter). Biotin-KIR and biotin-PEN5 (5H10) mAb were pro-
duced at Innate-Pharma and revealed with PerCP streptavidin (Bec-
ton Dickinson). NK cells were defined as the CD32CD56+ cells within
the lymphocyte size/granulometry gate. Two reciprocal NK cell sub-
sets were distinguished: KIR2NKG2A2 NK cells that do not express
KIR2DL1, KIR2DS1 (CD158a, h), KIR2DL2, KIR2DS2 (CD158b, j),
KIR2DS4 (CD158i), KIR3DL1 (CD158e1) or NKG2A (CD159a), and
KIR+NKG2A+ NK cells that express at least one of these receptors.
For KIR2DL1+KIR2DS12 donors, KIR2DL1+others2 NK cells were
defined as NK cells that stained positive with KIR2DL1, KIR2DS1
mAb and negative for a mixture of mAb reacting with KIR2DL2,
KIR2DS2, KIR2DS4, KIR3DL1, and NKG2A. Reciprocally for
KIR2DL2+KIR2DS22 donors, KIR2DL2+others2 NK cells were de-
fined as NK cells that stained positive with KIR2DL2, KIR2DS2
mAb and negative for a mixture of mAb reacting with KIR2DL1,
KIR2DS1, KIR2DS4, KIR3DL1, and NKG2A.
For CD107 mobilization, INF-g production, and perforin and gran-
zyme B detection, PBMC were incubated 4 hr at 37C in the pres-
ence of 5 mM monensin (Sigma), CD107 mAb, and various stimuli.
Cells were then washed in PBS 2 mM EDTA and stained for extracel-
lular markers. Thereafter, cells were fixed and permeabilized with In-
traPrep reagent (Beckman Coulter). Intracellular IFN-g, perforin, and
granzyme B were detected with Alexa 647-IFN-g (B27), PE-perforin
(dG9), and FITC-granzyme B (Gb11) (Becton Dickinson). Four-, five-,
and six-color fluorescent stainings were analyzed on a FACSCanto
with the FACSDiva software (Becton Dickinson). Results are pre-
sented as mean 6 SD of positive-stained cells, and statistical anal-
ysis has been performed with paired Student’s t tests.
Genotyping
Genomic DNA was isolated from mononuclear cells via a standard
salting-out method and quantified by spectrophotometry. KIR gen-
otyping was performed by PCR-SSOP (Crum et al., 2000), by PCR-
SSP with a PEL-FREEZ KIR Genotyping SSP Kit (Dynal Biotech,
Brown Deer, WI), and/or with the KIR-SSO kit from One-Lamda.
HLA-C typing was performed by PCR-SSOP (Williams et al., 2002)
or with the HLA-C-SSO kit from One-Lamda. As KIR2DL2 and
KIR2DL3 are alleles, they were both referred to as KIR2DL2. Simi-
larly, KIR3DL1 and KIR2DS1 alleles were referred to as KIR3DL1.
Supplemental Data
Two Supplemental Figures can be found with this article online at
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